End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
138.8 EUR | +1.86% |
|
0.00% | -12.66% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |